Back to resultsThe Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis
Primary Purpose
Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
Status
Active
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
The effect of Iyengar yoga practice on patients with multiple sclerosis
Sponsored by
About this trial
This is an interventional treatment trial for Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
Eligibility Criteria
Inclusion Criteria:
- age over 18 years
- diagnosis of multiple sclerosis
- EDSS grade 5 or higher
Exclusion Criteria:
- age less than 18 years
- the patient is not diagnosed with multiple sclerosis EDSS grade less than 5
- refusal of the subject to participate in the study
Sites / Locations
- University Hospital Motol
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
The effect of Iyengar yoga practice on patients with multiple sclerosis
Arm Description
Outcomes
Primary Outcome Measures
Hypothesis 1
Increase in respiratory amplitud. It will be measured by the meter.
Hypothesis 2
Increase in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.
Hypothesis 3
Increase in walking speed measured by T25FWT. It will by measured by stopwatch.
Hypothesis 4
Balance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.
Hypothesis 5
The quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.
Secondary Outcome Measures
Full Information
NCT ID
NCT05247372
First Posted
January 3, 2022
Last Updated
March 14, 2022
Sponsor
University Hospital, Motol
1. Study Identification
Unique Protocol Identification Number
NCT05247372
Brief Title
The Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis
Official Title
The Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
June 25, 2021 (Actual)
Primary Completion Date
June 30, 2022 (Anticipated)
Study Completion Date
June 30, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Motol
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this work is to find out what effect the practice of Iyengar yoga has on patients with multiple sclerosis on the EDSS 5 and more, specifically in the field of mobility, self-sufficiency and anxiety.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
The effect of Iyengar yoga practice on patients with multiple sclerosis
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
The effect of Iyengar yoga practice on patients with multiple sclerosis
Intervention Description
The study will be conducted as a longitudinal follow-up - at first patients will fbe examined 2 months before the start of the exercise, than they will be examined at the beginning and end of the exercise, which they will attend for 3 months. Patients will be re-examined 2 months after the end of the exercise to clarify the continuing effect of the exercise. The examination will include a basic kinesiological analysis and a neurological examination,TUG test, 6MWT along with the Borg Subjective Weight Rating Scale and T25FWT, BBS, NHPT and stable sitting time in wheelchairs. To evaluate the development of the chest, the respiratory amplitude will be examined and the position of the spine in statics and dynamics will be evaluated using a spinal mouse. Quality of life will be assessed through the MFIS, MSIS-29, MSQOL 54 questionares and Beck's anxiety inventory.
Primary Outcome Measure Information:
Title
Hypothesis 1
Description
Increase in respiratory amplitud. It will be measured by the meter.
Time Frame
3 months
Title
Hypothesis 2
Description
Increase in spinal development in the sagittal and frontal plane. It will by measured by spinal mouse.
Time Frame
3 months
Title
Hypothesis 3
Description
Increase in walking speed measured by T25FWT. It will by measured by stopwatch.
Time Frame
3 months
Title
Hypothesis 4
Description
Balance improvement in the Berg balance scale. It will be measured by the Berg balance scale questionare.
Time Frame
3 months
Title
Hypothesis 5
Description
The quality of life of patients with MS is improved subjectively evaluated through MSQOL54 questionare.
Time Frame
3 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age over 18 years
diagnosis of multiple sclerosis
EDSS grade 5 or higher
Exclusion Criteria:
age less than 18 years
the patient is not diagnosed with multiple sclerosis EDSS grade less than 5
refusal of the subject to participate in the study
Facility Information:
Facility Name
University Hospital Motol
City
Prague
State/Province
Czech Republic
ZIP/Postal Code
15006
Country
Czechia
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
The Effect of Iyengar Yoga Practice on Patients With Multiple Sclerosis
We'll reach out to this number within 24 hrs